Tumor samples from 231 CRC patients were used to analyze the correlation between RSL1D1 expression and the clinicopathological characteristics or prognosis of CRC patients by immunohistochemical (IHC) staining. The gene discussed is RSL1D1; the disease is colorectal carcinoma.